People · Operator
Named in public records as an officer, director or promoter · active 2010–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Theranostics Health, Inc. | — | Biotechnology | Seed | $10.9M | $10.0M | 2010 |
Glenn D Hoke, PhD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Glenn D Hoke, PhD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mitchell P Cybulski | 1 | 2 |
| Michael Dendy Young | 1 | 2 |
| Kevin G Quinn | 1 | 2 |
| William D King | 1 | 1 |
| Joseph S Bailes, MD | 1 | 1 |
| Eric M Eastman, PhD | 1 | 1 |
| Luis T Gutierrez, Jr | 1 | 1 |
| Mitchell S Cybulski | 1 | 1 |
| James N Cooper, MD | 1 | 1 |
| Barry S Strauch, MD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.